Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Forbes Medi-Tech study

This article was originally published in The Tan Sheet

Executive Summary

University of British of Columbia trial, expected to begin in May, will examine effects of phytosterol and phytosterol/omega-3 softgel supplements on LDL cholesterol. Four-arm study will investigate sterol/omega combination, sterols only, omega-3 only and placebo. Protocol calls for lipid measurements after six-week treatment period and six-week washout. Vancouver-based Forbes says it is in "discussions with two multinational pharmaceutical companies" on possible licensing, partnership arrangements and hopes to get supplements to market by year-end. Also, Forbes announces plans to sell its phytosterol pilot manufacturing facility in Quebec for approximately $1 mil...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093914

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel